Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Evidence of antiviral activity for ISIS-14803 in chronic hepatitis C

Oct. 31, 2003

Encouraging topline results from phase III trials of cilansetron

Oct. 31, 2003

Preclinical efficacy, safety and PK data discussed for IDN-6556 at AASLD meeting

Oct. 28, 2003

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Top-line results from third phase III study of Entereg for postoperative ileus

Oct. 27, 2003

Positive preliminary results announced for tolevamer in C. difficile diarrhea

Oct. 23, 2003

Beneficial effects of rifaximin in Crohn's disease

Oct. 22, 2003

Pegasys approved in Japan

Oct. 21, 2003

Encouraging six-month results from phase II study of merimepodib in HCV

Oct. 21, 2003

Metabasis receives SBIR grant for efforts in hepatitis C

Oct. 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.